Although it may not be the same, the concept of administering a drug for ‘prevention’ has been around for a while.

Patients who have chronic diseases have been taking drugs to ‘manage’ their condition rather than treat it. Also, some drugs just exist to prevent a condition, like anticoagulants.

The same has just recently been applied to anticancer drugs. Companies have been acquiring or seeking indications as adjuvant or neo-adjuvant therapy for early-stage disease with their various new anticancer drugs through various research.

Even at the 'American Society of Clinical Oncology 2023 Annual Meeting’ that is being held in Chicago, USA, adjuvant therapy research data a